Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Liabilities from Discontinued Operations (2020 - 2021)

Palisade Bio has reported Liabilities from Discontinued Operations over the past 2 years, most recently at 219757.0 for Q1 2021.

  • Quarterly Liabilities from Discontinued Operations changed N/A to 219757.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was 219757.0 through Mar 2021, changed N/A year-over-year, with the annual reading at 234344.0 for FY2020, N/A changed from the prior year.
  • Liabilities from Discontinued Operations was 219757.0 for Q1 2021 at Palisade Bio, down from 234344.0 in the prior quarter.
  • Over five years, Liabilities from Discontinued Operations peaked at 325812.0 in Q3 2020 and troughed at 219757.0 in Q1 2021.